Efficacy of laparoscopic surgery and post-operation medicine for ovarian endometrioma

In: China Modern Doctor · 2012 · W2359180724
article OA: closed CC0
View on OpenAlex
AI-generated summary by qwen3.7-flash, 2026-08-23

This study found that postoperative GnRH-a or gestrinone reduces ovarian endometrioma recurrence after laparoscopic surgery compared to no treatment, with GnRH-a exhibiting fewer side effects than gestrinone.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To evaluate the efficacy of laparoscopic surgery and post-operation medicine for ovarian endometrioma.Methods All of 239 patients with ovarian endometrioma who were treated with ovarian cystectomy performed by laparoscopy were divided into three groups: untreated group,GnRH-a group,gestrinone group.The recurrence rate of the three groups and the side effects of the two kinds of medicine were compared.Results All the patients were followed up for 18 to 42 months,and the incidence of recurrence in the untreated group was higher than in GnRH-a group and gestrinone group(P 0.05),but there was no statistically significant difference between GnRH-a group and gestrinone group(P 0.05).The incidence of side effect in GnRH-a group was lower than gestrinone group.Conclusion Laparoscopic surgery is an effective way to treat ovarian endometrioma,and the use of GnRH-a or gestrinone after operation can reduce the incidence of recurrence,but the incidence of side effect in the gestrinone group is higher.

My notes (saved in your browser only)

Condition tags

endometrioma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK